FCMI
Foresite Capital Management I Portfolio holdings
AUM
$21.4M
This Quarter Return
+20.47%
1 Year Return
-80.48%
3 Year Return
-40.72%
5 Year Return
–
10 Year Return
–
AUM
$141M
AUM Growth
+$141M
(+38%)
Cap. Flow
+$16.6M
Cap. Flow
% of AUM
11.75%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
3
Increased
–
Reduced
1
Closed
–
Top Buys
| 1 |
OREX
Orexigen Therapeutics, Inc.
OREX
|
$8.13M |
| 2 |
BDSI
BioDelivery Sciences International, Inc.
BDSI
|
$5.91M |
| 3 |
RXDX
Ignyta, Inc.
RXDX
|
$4.15M |
Top Sells
| 1 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$1.56M |
Sector Composition
| 1 | Healthcare | 86.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Karyopharm Therapeutics
KPTI
$61.7M
| $49M | 34.41% | 1,585,743 | – | – |
|
|
KERX
2
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $22.4M | 15.71% | 1,312,006 | – | – |
|
|
AMBI
3
DELISTED
AMBIT BIOSCIENCES CORP COM STK (DE)
AMBI
| $19M | 13.32% | 2,079,569 | – | – |
|
4
Talphera
TLPH
$11.1M
| $16.6M | 11.64% | 1,379,080 | – | – |
|
5
Xencor
XNCR
$580M
| $9.62M | 6.76% | 820,000 | – | – |
|
|
OREX
6
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $8.13M | 5.71% | +1,250,000 | New | +$8.13M |
|
7
Novavax
NVAX
$1.21B
| $6.05M | 4.25% | 1,336,200 | – | – |
|
|
BDSI
8
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $5.91M | 4.15% | +700,000 | New | +$5.91M |
|
|
RXDX
9
DELISTED
Ignyta, Inc.
RXDX
| $4.15M | 2.92% | +500,000 | New | +$4.15M |
|
|
XLRN
10
DELISTED
Acceleron Pharma Inc.
XLRN
| $721K | 0.51% | 20,892 -45,108 | -68% | -$1.56M |
|